August 18, 2026
A Comprehensive Review of the Mechanism, Efficacy, Safety, and Clinical Implications of Eli Lilly's Foundayo (Orforglipron)
A Comprehensive Review of the Mechanism, Efficacy, Safety, and Clinical Implications of Eli Lilly's Foundayo (Orforglipron)
Product information updates for desogestrel/etonogestrel and meningioma, levonorgestrel intrauterine systems and ectopic pregnancy, and information concerning atogepant and insomnia, CGRP antagonists and Raynaud's phenomenon, oseltamivir safety in critically ill patients, sacituzumab govitecan and interstitial lung disease, selpercatinib and intestinal lymphangiectasia, and sevoflurane and acute encephalopathy in patients carrying the mitochondrial DNA variant m.11232T>C.
The digital revolution—encompassing AI, machine learning, big data analytics, EHRs, mobile applications, and social media monitoring—is reshaping how ADRs are detected, assessed, and prevented.
This essay provides a comprehensive examination of RCA methodologies within, exploring the application of Six Sigma and DMAIC frameworks, the A3 problem-solving approach, and the essential analytical tools including Pareto diagrams, the Five Whys technique, and fishbone (Ishikawa) diagrams.
Angioedema with darolutamide, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome with gemcitabine, neurodevelopmental disorders with paternal valproate exposure, fixed drug eruption with iodinated X-ray contrast agents, and protein-losing gastroenteropathy with zolbetuximab.
Insulin Syringe Safety, Drug-Drug Interactions with Valproic Acid and Methotrexate, and Denosumab-Induced Mineral Metabolism Disturbances
The Egyptian Drug Authority (EDA) published its third version of the Good Pharmacovigilance Practice (GVP) guideline in 2026, representing a significant evolution in Egypt's pharmacovigilance regulatory framework.
Advancing Medication Safety Through Knowledge and Vigilance
